Healthcare knowledge provider BMJ has announced Carl Heneghan as the new Editor-in-Chief of BMJ Evidence-Based Medicine.
Carl Heneghan is Professor of Evidence-Based Medicine (EBM) and Director of the Centre for Evidence-Based Medicine (CEBM) at Oxford University's Nuffield Department of Primary Care Health Sciences. CEBM is dedicated to the practice, teaching and dissemination of high quality EBM and making EBM accessible to a wide range of healthcare professionals.
Carl is a clinical epidemiologist and a world-leading expert in EBM and research methods. He has extensive experience in systematic reviews and quantitative methodologies on both communicable and non-communicable diseases. He has also led ground-breaking work, which notably includes the Tamiflu systematic reviews, as well as investigations into the evidence base for drug and device regulation, advising governments and influencing policy. An accomplished academic, investigator, teacher, and author, all his work focuses on changing healthcare for the better.
BMJ Evidence-Based Medicine publishes original evidence based research, insights and opinions on what matters for healthcare. The journal focuses on the tools, methods, and concepts that are basic and central to practising evidence-based medicine. It is one of 60 specialist journals published by BMJ.
Carl Heneghan will take over as Editor-in-Chief from Richard Saitz from June 21, 2017.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
